Patient-Reported AEs and Treatment Discontinuation in Patients With Multiple Myeloma
This secondary analysis of the ECOG-ACRIN E1A11 trial analyzes the association of patient-reported adverse effects with early treatment discontinuation in patients with multiple myeloma.